Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200414524> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4200414524 endingPage "S715" @default.
- W4200414524 startingPage "S715" @default.
- W4200414524 abstract "Abstract Background Treatment options for β-lactamase-producing Enterobacterales are limited, particularly for infections caused by metallo-β-lactamase (MBL)-producing strains. The β-lactam/non-β-lactam β-lactamase inhibitor combination aztreonam-avibactam (ATM-AVI) is active in vitro against Enterobacterales isolates carrying MBLs, including those co-producing β-lactamases of Class A, C, and some class D enzymes. This study evaluated the in vitro activity of ATM-AVI and comparators against Enterobacterales isolates collected in 2015-2019 from patients with bloodstream infections (BSI) as part of the ATLAS program. Methods Non-duplicate clinical isolates were collected in 53 countries in Europe, Latin America, Asia/Pacific (excluding mainland China and India), and Middle East/Africa. Susceptibility testing was performed by CLSI broth microdilution and interpreted using CLSI 2021 and FDA (tigecycline) breakpoints. ATM-AVI was tested at a fixed concentration of 4 µg/mL AVI. MDR was defined as resistant (R) to ≥3 of 7 sentinel drugs: amikacin, aztreonam, cefepime, colistin, levofloxacin, meropenem, and piperacillin-tazobactam. PCR and sequencing were used to determine the β-lactamase genes present in all isolates with meropenem MIC >1 µg/mL, and Escherichia coli, Klebsiella spp. and Proteus mirabilis phenotypically positive for ESBL activity (2015) or with aztreonam or ceftazidime MIC >1 µg/mL (2016-2019). Results ATM-AVI was active in vitro against Enterobacterales isolates from BSI (MIC90, 0.12 µg/mL), with 99.97% of isolates inhibited by ≤8 µg/mL of ATM-AVI, including 100% of isolates that produced MBLs. ATM-AVI tested with MIC90 values of 0.5 µg/mL against subsets of cefepime-nonsusceptible (NS), meropenem-NS, amikacin-NS, colistin-resistant, and MBL-positive Enterobacterales (Table). The tested β-lactam comparators showed susceptibility of < 79% against these subsets of resistant isolates. Results Table Conclusion Based on MIC90 values, ATM-AVI was the most potent agent tested against drug-resistant and MBL-positive subsets of Enterobacterales collected from BSI. The promising in vitro activity of ATM-AVI warrants further development of this combination for treatment of BSI caused by drug-resistant Enterobacterales. Disclosures Sibylle Lob, PhD, IHMA (Employee)Pfizer, Inc. (Independent Contractor) Krystyna Kazmierczak, PhD, IHMA (Employee)Pfizer, Inc. (Independent Contractor) Francis Arhin, PhD, Pfizer, Inc. (Employee) Daniel F. Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Independent Contractor)" @default.
- W4200414524 created "2021-12-31" @default.
- W4200414524 creator A5017159626 @default.
- W4200414524 creator A5030449858 @default.
- W4200414524 creator A5038009031 @default.
- W4200414524 creator A5066677972 @default.
- W4200414524 date "2021-11-01" @default.
- W4200414524 modified "2023-09-27" @default.
- W4200414524 title "1252. In Vitro Activity of Aztreonam-Avibactam and Comparator Agents Against Enterobacterales from Patients with Bloodstream Infections collected during the ATLAS Global Surveillance Program, 2015-2019" @default.
- W4200414524 doi "https://doi.org/10.1093/ofid/ofab466.1444" @default.
- W4200414524 hasPublicationYear "2021" @default.
- W4200414524 type Work @default.
- W4200414524 citedByCount "0" @default.
- W4200414524 crossrefType "journal-article" @default.
- W4200414524 hasAuthorship W4200414524A5017159626 @default.
- W4200414524 hasAuthorship W4200414524A5030449858 @default.
- W4200414524 hasAuthorship W4200414524A5038009031 @default.
- W4200414524 hasAuthorship W4200414524A5066677972 @default.
- W4200414524 hasBestOaLocation W42004145241 @default.
- W4200414524 hasConcept C104317684 @default.
- W4200414524 hasConcept C176947019 @default.
- W4200414524 hasConcept C2777027569 @default.
- W4200414524 hasConcept C2777050379 @default.
- W4200414524 hasConcept C2777058267 @default.
- W4200414524 hasConcept C2777402170 @default.
- W4200414524 hasConcept C2777406300 @default.
- W4200414524 hasConcept C2777427914 @default.
- W4200414524 hasConcept C2779259085 @default.
- W4200414524 hasConcept C2779375183 @default.
- W4200414524 hasConcept C2779631663 @default.
- W4200414524 hasConcept C2780416669 @default.
- W4200414524 hasConcept C2780950330 @default.
- W4200414524 hasConcept C501593827 @default.
- W4200414524 hasConcept C547475151 @default.
- W4200414524 hasConcept C55493867 @default.
- W4200414524 hasConcept C71924100 @default.
- W4200414524 hasConcept C86803240 @default.
- W4200414524 hasConcept C89423630 @default.
- W4200414524 hasConcept C94665300 @default.
- W4200414524 hasConceptScore W4200414524C104317684 @default.
- W4200414524 hasConceptScore W4200414524C176947019 @default.
- W4200414524 hasConceptScore W4200414524C2777027569 @default.
- W4200414524 hasConceptScore W4200414524C2777050379 @default.
- W4200414524 hasConceptScore W4200414524C2777058267 @default.
- W4200414524 hasConceptScore W4200414524C2777402170 @default.
- W4200414524 hasConceptScore W4200414524C2777406300 @default.
- W4200414524 hasConceptScore W4200414524C2777427914 @default.
- W4200414524 hasConceptScore W4200414524C2779259085 @default.
- W4200414524 hasConceptScore W4200414524C2779375183 @default.
- W4200414524 hasConceptScore W4200414524C2779631663 @default.
- W4200414524 hasConceptScore W4200414524C2780416669 @default.
- W4200414524 hasConceptScore W4200414524C2780950330 @default.
- W4200414524 hasConceptScore W4200414524C501593827 @default.
- W4200414524 hasConceptScore W4200414524C547475151 @default.
- W4200414524 hasConceptScore W4200414524C55493867 @default.
- W4200414524 hasConceptScore W4200414524C71924100 @default.
- W4200414524 hasConceptScore W4200414524C86803240 @default.
- W4200414524 hasConceptScore W4200414524C89423630 @default.
- W4200414524 hasConceptScore W4200414524C94665300 @default.
- W4200414524 hasIssue "Supplement_1" @default.
- W4200414524 hasLocation W42004145241 @default.
- W4200414524 hasLocation W42004145242 @default.
- W4200414524 hasOpenAccess W4200414524 @default.
- W4200414524 hasPrimaryLocation W42004145241 @default.
- W4200414524 hasRelatedWork W2072511609 @default.
- W4200414524 hasRelatedWork W2138307447 @default.
- W4200414524 hasRelatedWork W2158629630 @default.
- W4200414524 hasRelatedWork W2961597065 @default.
- W4200414524 hasRelatedWork W3081398208 @default.
- W4200414524 hasRelatedWork W3093131361 @default.
- W4200414524 hasRelatedWork W4200414524 @default.
- W4200414524 hasRelatedWork W4224942196 @default.
- W4200414524 hasRelatedWork W4306644058 @default.
- W4200414524 hasRelatedWork W4311615639 @default.
- W4200414524 hasVolume "8" @default.
- W4200414524 isParatext "false" @default.
- W4200414524 isRetracted "false" @default.
- W4200414524 workType "article" @default.